Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis.
Zhou Y, Li A, Yu H, Wang Y, Zhang X, Qiu H, Du W, Luo L, Fu S, Zhang L, Hong S.
JAMA Netw Open. 2024 Mar 4;7(3):e241285. doi: 10.1001/jamanetworkopen.2024.1285.
PMID:38451524
Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis.
Llano-León M, Martínez-Enriquez LC, Rodríguez-Bohórquez OM, Velandia-Vargas EA, Lalinde-Ruíz N, Villota-Álava MA, Rodríguez-Rodríguez IJ, Montilla-Velásquez MDP, Parra-López CA.